Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 15/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4449334 | 0.89 | ALDH1A1 (0.43) | CHRM3CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4453379 | 0.86 | ALDH1A1 (0.46) | CHRM3CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4457740 | 0.85 | CHRM3 (0.41) | CHRM3CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL1134839 | 0.85 | CHRM3 (0.46) | CHRM3CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL11930691 | 0.84 | ALDH1A1 (0.57) | ALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL344392 | 0.84 | CHRM3 (0.46) | CHRM3CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4922992 | 0.84 | ALDH1A1 (0.49) | CHRM3CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL13455819 | 0.82 | ALDH1A1 (0.49) | CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL4446444 | 0.82 | CYP1A2 (0.46) | CHRM3CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4456702 | 0.82 | TACR1 (0.47) | CHRM3CYP1A2CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090042725-A1 | Fungicidal Mixtures Based on 3,5-Disubstituted N-Biphenyl-Pyrazolcarboxamides | BASF AKTIENGESELLSCHAFT (DE) | 2009-02-12 | — | — | US | claimed |
| US-20090042725-A1 | Fungicidal Mixtures Based on 3,5-Disubstituted N-Biphenyl-Pyrazolcarboxamides | BASF AKTIENGESELLSCHAFT (DE) | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042725-A1 | Fungicidal Mixtures Based on 3,5-Disubstituted N-Biphenyl-Pyrazolcarboxamides | CBR3, CBR1, STS | CHRM3 328/4885CYP1A2 55/4885CYP3A4 264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.